ATNM vs. BBOT

Last updated Jun 24, 2026

ATNM (Actinium Pharmaceuticals, Inc.) and BBOT (BridgeBio Oncology Therapeutics, Inc) are both stocks. Both operate in the Biotechnology industry within the Healthcare sector. At a 0.10 correlation, their price movements are largely independent.

Performance

ATNM vs. BBOT - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Actinium Pharmaceuticals, Inc. (ATNM) and BridgeBio Oncology Therapeutics, Inc (BBOT). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, ATNM achieves a -25.00% return, which is significantly higher than BBOT's -40.10% return.

ATNM

• 1D: -0.97%
• 1M: -13.56%
• YTD: -25.00%
• 6M: -35.44%
• 1Y: -32.89%
• 3Y*: -48.60%
• 5Y*: -33.49%
• 10Y*: -32.45%

BBOT

• 1D: -4.70%
• 1M: -12.28%
• YTD: -40.10%
• 6M: -37.13%
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

ATNM vs. BBOT - Yearly Performance Comparison

	2026 (YTD)	2025
ATNM Actinium Pharmaceuticals, Inc.	-25.00%	-7.48%
BBOT BridgeBio Oncology Therapeutics, Inc	-40.10%	22.75%

Correlation

The correlation between ATNM and BBOT is 0.10, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (All Time) Calculated using the full available price history since Aug 12, 2025	0.10

Fundamentals

Market Cap ATNM : $31.86M BBOT : $600.24M
EPS ATNM : -$0.75 BBOT : -$3.90
Total Revenue (TTM) ATNM : $90.00K BBOT : $0.00
Gross Profit (TTM) ATNM : $485.00K BBOT : -$194.00K
EBITDA (TTM) ATNM : -$24.68M BBOT : -$168.31M

Return for Risk

ATNM vs. BBOT — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ATNM

ATNM Risk / Return Rank: 20
ATNM Sharpe Ratio Rank: 20
ATNM Sortino Ratio Rank: 22
ATNM Omega Ratio Rank: 23
ATNM Calmar Ratio Rank: 16
ATNM Martin Ratio Rank: 17

BBOT

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ATNM vs. BBOT - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Actinium Pharmaceuticals, Inc. (ATNM) and BridgeBio Oncology Therapeutics, Inc (BBOT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	ATNM	BBOT	Difference
Sharpe ratio: Return per unit of total volatility	-0.50	—	—
Sortino ratio: Return per unit of downside risk	-0.47	—	—
Omega ratio: Gain probability vs. loss probability	0.95	—	—
Calmar ratio: Return relative to maximum drawdown	-0.69	—	—
Martin ratio: Return relative to average drawdown	-1.15	—	—

Drawdowns

ATNM vs. BBOT - Drawdown Comparison

The maximum ATNM drawdown since its inception was -99.75%, which is greater than BBOT's maximum drawdown of -48.14%. Use the drawdown chart below to compare losses from any high point for ATNM and BBOT.

Drawdown Indicators

	ATNM	BBOT	Difference
Max Drawdown Largest peak-to-trough decline	-99.75%	-48.14%	-51.61%
Max Drawdown (1Y) Largest decline over 1 year	-47.59%	—	—
Max Drawdown (3Y) Largest decline over 3 years	-90.09%	—	—
Max Drawdown (5Y) Largest decline over 5 years	-93.20%	—	—
Max Drawdown (10Y) Largest decline over 10 years	-98.37%	—	—
Current Drawdown Current decline from peak	-99.74%	-45.38%	-54.36%
Average Drawdown Average peak-to-trough decline	-85.42%	-20.56%	-64.86%
Ulcer Index Depth and duration of drawdowns from previous peaks	28.75%	—	—

Volatility

Volatility by Period

	ATNM	BBOT	Difference
Volatility (1M) Calculated over the trailing 1-month period	16.73%	—	—
Volatility (6M) Calculated over the trailing 6-month period	44.99%	—	—
Volatility (1Y) Calculated over the trailing 1-year period	65.44%	70.40%	-4.96%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	79.87%	70.40%	+9.47%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	81.43%	70.40%	+11.03%

Dividends

ATNM vs. BBOT - Dividend Comparison

Neither ATNM nor BBOT has paid dividends to shareholders.

Tickers have no history of dividend payments

Financials

Frequently Asked Questions

Can I hold both ATNM and BBOT in my portfolio?

ATNM and BBOT have a correlation of 0.10, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.